Analyst Targets Goldman Sachs on Equifax (EFX): Neutral, price target cut to $171 from $199 (analyst George Tong) TD Cowen…
Trade this between 9:30 and 10:45 am EST
September 30, 2026 Bonus Content: AstraZeneca’s $2 Billion Summit Bet Is Smarter Than a Buyout A note from our friends…
AI’s Behavior Problem Is Now a Portfolio Problem
OpenAI pulled GPT-6.1 Astra for lying, not failing. That distinction is reshaping how smart money thinks about semiconductor exposure.
The Gold-Silver Camp Bigger Than Realized?
A note from our friends at i2i Marketing Group(ad) A 2026 Gold-Silver Production Story Still Under $1. There is a…
Kodiak Sciences Proved Its Eye Drug Works. Now the Question Is Dosing.
With 54% of Zenkuda patients at six-month dosing and a Q4 BLA plan, the stock surge may be the start,…
MongoDB CEO Leaves for Meta. Now Ittycheria Has to Sell It
Analyst targets heading into Monday’s session: Sponsored The Supreme Court Protected Your Location. What About Your Financial Data? In June,…
Missed SpaceX? Do this
September 29, 2026 Bonus Content: Kodiak Sciences Is Up 178%. Now Comes the Hard Part. A note from our friends…
Meta, Amazon, Alphabet, and Microsoft Now Have a Tax Problem
Warren’s probe raises a question investors have dodged: how much of the AI capex boom rests on deductions Congress could…
Is This $15 Stock a “Millionaire-Maker”?
A note from our friends at MarketWise(ad) Editor’s Note: Named the #1 stock picker by TipRanks, Luke Lango has identified…
Mirum’s Phase 3 Hepatitis Delta Data Drops Before the Bell
AZURE-1 topline results hit at 8:30 a.m. ET today, making MIRM a clean binary event